Gary Bridger
Impact in
- Hematology top 0.1%
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Virology top 0.5%
- HIV Research and Treatment
Papers in
- Immunology 50
- Immunotherapy and Immune Responses 26
- Immune Cell Function and Interaction 20
- Oncology 47
- Chemokine receptors and signaling 43
- Co-authors
- Renato T. Skerlj (37 shared papers)Dominique Schols (32 shared papers)Geoffrey Henson (19 shared papers)Gary Calandra (16 shared papers)Erik De Clercq (28 shared papers)John F. DiPersio (22 shared papers)Sigrid Hatse (17 shared papers)Thue W. Schwartz (10 shared papers)
- Journals
- Blood (25 papers)Journal of Medicinal Chemistry (7 papers)Biology of Blood and Marrow Transplantation (6 papers)The Journal of Organic Chemistry (5 papers)Molecular Pharmacology (5 papers)
- Partner nations
- United StatesBelgiumUnited Kingdom
In The Last Decade
Gary Bridger
118 papers receiving 9.7k citations
Gary Bridger's Hit Papers
Peers
Comparison fields: 5 of 118
- Hematology 3.2k
- Virology 1.2k
- Immunology 3.8k
- Oncology 4.2k
- Genetics 590
Countries citing papers authored by Gary Bridger
This map shows the geographic impact of Gary Bridger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Bridger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Bridger more than expected).
Fields of papers citing papers by Gary Bridger
This network shows the impact of papers produced by Gary Bridger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Bridger. The network helps show where Gary Bridger may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary Bridger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist Hit paper breakdown → | 2005 | 850 |
| 2 | Chemokines Acting via CXCR2 and CXCR4 Control the Release of Neutrophils from the Bone Marrow and Their Return following Senescence Hit paper breakdown → | 2003 | 584 |
| 3 | Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma Hit paper breakdown → | 2009 | 581 |
| 4 | Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist Hit paper breakdown → | 2003 | 563 |
| 5 | Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma Hit paper breakdown → | 2009 | 513 |
| 6 | 2000 | 406 | |
| 7 | Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. | 2002 | 403 |
| 8 | 2008 | 388 | |
| 9 | 2002 | 382 | |
| 10 | 2004 | 285 | |
| 11 | 2008 | 236 | |
| 12 | 2001 | 229 | |
| 13 | 2007 | 221 | |
| 14 | 2001 | 215 | |
| 15 | 2004 | 197 | |
| 16 | 1995 | 193 | |
| 17 | 2002 | 166 | |
| 18 | 2006 | 142 | |
| 19 | 1989 | 120 | |
| 20 | 2002 | 114 |
About Gary Bridger
Gary Bridger is a scholar working on Immunology, Oncology, Hematology, Virology and Molecular Biology, having authored 118 papers that have together received 10.0k indexed citations. Recurring topics across this work include Chemokine receptors and signaling (43 papers), HIV Research and Treatment (33 papers), Hematopoietic Stem Cell Transplantation (28 papers), Immunotherapy and Immune Responses (26 papers), Immune Cell Function and Interaction (20 papers), Multiple Myeloma Research and Treatments (15 papers), Acute Myeloid Leukemia Research (15 papers) and HIV/AIDS drug development and treatment (13 papers). The work is most often cited by research in Hematology (3.2k citations), Virology (1.2k citations), Immunology (3.8k citations), Oncology (4.2k citations) and Genetics (590 citations). Gary Bridger has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Renato T. Skerlj, Dominique Schols, Geoffrey Henson, Gary Calandra, Erik De Clercq, John F. DiPersio, Sigrid Hatse, Thue W. Schwartz, Richard T. Maziarz and Simon P. Fricker. Their work appears in journals such as Blood, Journal of Medicinal Chemistry, Biology of Blood and Marrow Transplantation, The Journal of Organic Chemistry and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.